ClinicalTrials.Veeva

Menu

Anti Inflammatory Treatment of Hypertension

A

Affiliated Hospital of North Sichuan Medical College

Status and phase

Completed
Phase 3
Phase 2

Conditions

Hypertension

Treatments

Drug: Levamlodipine
Drug: Amlodipine

Study type

Interventional

Funder types

Other

Identifiers

NCT04740840
AHNorthSichuanMC

Details and patient eligibility

About

To investigate the anti-inflammatory effect of amlodipine and levamlodipine in the treatment of hypertension

Full description

A total of 200 inpatients or outpatients in the Department of cardiovascular medicine of the third people's Hospital of Mianyang City from April 2021 to October 2021, who met the diagnostic criteria of ish2020 international hypertension practice guidelines, were selected and randomly divided into control group and experimental group, with 100 cases in each group. The control group was treated with amlodipine and the experimental group was treated with levoamlodipine. The changes of blood pressure and serum inflammatory factors were observed before and after treatment.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ① In line with the diagnostic criteria of ISH2020 International Guidelines for Practice of Hypertension ② Age >18 years old, gender is not limited, during the treatment did not take other drugs that will affect blood pressure: such as antidepressants, oral contraceptives, Chinese herbal medicine, etc.; Voluntary participation and signing of informed consent, and can complete all the visit plan.

Exclusion criteria

  • (1) Those who do not want to take blood tests; (2) Left ventricular ejection fraction < 50%, heart rate <50 beats/min; ③ Acute coronary syndrome (unstable angina pectoris and myocardial infarction); ④ valvular heart disease, congenital heart disease, etc.; Other infectious diseases and malignant tumors; ⑥ Bronchial asthma; ⑦ Abnormal liver function and renal dysfunction (ALT BBB 0 80U/L, CR BBB 1 442mmol/L); Autoimmune diseases or any serious and fatal diseases; ⑨ Receiving lipid-lowering therapy and oral vitamins or antioxidants; They are mentally ill, have no self-awareness, and are unable to express themselves or cooperate with others.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

200 participants in 2 patient groups

Levamlodipine group
Experimental group
Description:
Blood pressure lowering therapy with 2.5mg levamlodipine, plus metoprolol succinate
Treatment:
Drug: Levamlodipine
Amlodipine group
Sham Comparator group
Description:
To receive 5mg amlodipine to lower blood pressure, plus metoprolol succinate
Treatment:
Drug: Amlodipine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems